The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K. Baumgartner, Joshua H. Decker, Hakimeh Ebrahimi-Nik et al.|Nature|2023Cited by 170
Melanoma and microbiota: Current understanding and future directionsBertrand Routy, Laurence Zitvogel, Laura Mählmann et al.|Cancer Cell|2023Cited by 78
Peptide-MHC Class II Complex Stability Governs CD4 T Cell Clonal SelectionChristina K. Baumgartner, Laurent Malherbe, Andrea Ferrante et al.|The Journal of Immunology|2009Cited by 46
Immune tolerance induced by platelet‐targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediatedY. Chen, Qizhen Shi, Xiang Luo et al.|Journal of Thrombosis and Haemostasis|2017Cited by 34
Regulation of CD4 T‐cell receptor diversity by vaccine adjuvantsChristina K. Baumgartner, Laurent Malherbe|Immunology|2010Cited by 26